Tickers

1. Composite Trajectory Verdict

For a capital-intensive beverage alcohol company managing high leverage, ongoing brewery expansion, and a strategic portfolio shift, cash generation and balance sheet deleveraging carry the most weight alongside reported profitability.

Composite Trajectory: Mixed

The annual GAAP earnings trajectory reversed sharply from a $81.4 million net loss in FY2025 (driven by a $2.8 billion goodwill impairment) to $1.69 billion net income in FY2026, but this recovery coincides with a 10% net sales decline to $9.14 billion (10-K FY2026, Consolidated Statements of Comprehensive Income). Operating cash flow fell 15% to $2.67 billion while capital expenditures remained high at $875 million (10-K FY2026, Consolidated Statements of Cash Flows). The balance sheet improved materially: total debt decreased $929 million to $10.57 billion and debt-to-equity improved from 1.61x to 1.26x (10-K FY2026, MD&A Liquidity and Capital Resources; Consolidated Balance Sheets). Beer segment shipments declined 3.8% while Wine and Spirits organic shipments fell 6.7% (10-K FY2026, MD&A Results of Operations). The divergence between recovering GAAP profits, declining volumes, lower operating cash flow, and strengthening leverage creates a mixed picture.

2. Red Flags

• GAAP earnings recovery driven by non-recurring impairment reversal, not operating improvement: FY2026 net income of $1.69 billion vs. FY2025 net loss of $81.4 million, but FY2025 included $2.8 billion goodwill/intangible impairment and $478 million asset impairment; FY2026 included $110 million asset impairment and $32 million loss on divestiture (10-K FY2026, Consolidated Statements of Comprehensive Income).
• Operating cash flow declined 15% while net income rose: Operating cash flow fell from $3.15 billion (FY2025) to $2.67 billion (FY2026) despite net income swinging from -$31 million to +$1.76 billion (10-K FY2026, Consolidated Statements of Cash Flows).
• Beer shipment volume declining for two consecutive years: Shipments fell 3.8% to 415.4 million cases in FY2026 after 431.8 million in FY2025 (10-K FY2026, MD&A Results of Operations).
• Wine and Spirits organic volume decline accelerating: Organic shipments fell 6.7% in FY2026 vs. 7.4% decline in U.S. wholesale organic shipments (10-K FY2026, MD&A Results of Operations).
• Gross margin compression in both segments: Beer gross margin fell 185 bps; Wine and Spirits gross margin fell ~20 bps organically (10-K FY2026, MD&A Gross profit).
• Rising SG&A as percentage of net sales: Consolidated SG&A ratio increased to 20.2% from 19.1% (10-K FY2026, MD&A SG&A expenses).
• Significant tariff impact on Beer cost of goods sold: $58.3 million in Section 232 aluminum tariffs in FY2026 (10-K FY2026, MD&A Gross profit).
• Large near-term debt maturities: $604 million due in FY2027, $1.8 billion in FY2028 (10-K FY2026, Note 13 Debt payments).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

GAAP net income attributable to CBI swung from a $81.4 million loss in FY2025 to $1.69 billion in FY2026, but this primarily reflects the absence of FY2025's $2.8 billion goodwill/intangible impairment and $478 million asset impairment (10-K FY2026, Consolidated Statements of Comprehensive Income). Net sales declined 10% to $9.14 billion, driven by a 51% drop in Wine and Spirits net sales (largely from divestitures) and a 3% decline in Beer net sales (10-K FY2026, MD&A Results of Operations). Beer operating income fell 7% to $3.16 billion on lower shipments and higher COGS (including $58 million tariffs), partially offset by pricing and $200 million efficiency benefits (10-K FY2026, MD&A Results of Operations). Wine and Spirits operating income collapsed 97% to $10.5 million, reflecting divestitures and organic volume/mix declines (10-K FY2026, MD&A Results of Operations). Diluted EPS recovered to $9.61 from -$0.45 (10-K FY2026, Consolidated Statements of Comprehensive Income).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Deteriorating

Operating cash flow declined 15% to $2.67 billion in FY2026 from $3.15 billion in FY2025, despite net income improving by $1.79 billion (10-K FY2026, Consolidated Statements of Cash Flows). The decline was driven by a $51 million unfavorable change in working capital (higher Beer receivables, lower payables) and lower cash tax payments (10-K FY2026, MD&A Cash Flows). Investing cash flow turned positive at $16.5 million due to $850.5 million divestiture proceeds, vs. -$975 million in FY2025 (10-K FY2026, Consolidated Statements of Cash Flows). Capital expenditures remained elevated at $875 million, primarily for Brewery Projects (10-K FY2026, MD&A Capital Expenditures). Financing cash outflows increased to $2.66 billion, reflecting $924 million share repurchases, $716 million dividends, and $951 million net debt repayment (10-K FY2026, Consolidated Statements of Cash Flows). Free cash flow (operating minus capex) decreased to ~$1.79 billion from ~$1.94 billion in FY2025.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Improving

Total debt decreased $929 million to $10.57 billion at FY2026 year-end from $11.50 billion at FY2025 (10-K FY2026, MD&A Debt). Short-term borrowings (commercial paper) fell from $807 million to $272 million; current maturities of long-term debt fell from $1.40 billion to $604 million (10-K FY2026, Consolidated Balance Sheets). Total stockholders' equity rose 17.5% to $8.39 billion from $7.13 billion, driven by $1.69 billion net income and $1.09 billion OCI gain (foreign currency and derivatives), partially offset by $924 million share repurchases and $716 million dividends (10-K FY2026, Consolidated Statements of Changes in Stockholders' Equity). Debt-to-equity improved to 1.26x from 1.61x. The revolving credit facility had $1.97 billion available as of February 28, 2026 (10-K FY2026, MD&A Bank facilities). Interest coverage (operating income/interest expense) improved to 7.7x from 0.9x (impairment-distorted) in FY2025, consistent with FY2024's 7.3x (10-K FY2026, Consolidated Statements of Comprehensive Income; MD&A Interest expense).

6. Data Gaps

• Quarterly revenue, earnings, and cash flow trends for FY2026 quarters (Q1-Q4) and FY2027 Q1: 10-Q filings listed in the document set were truncated and their financial statement data is not available for citation.
• FY2024 balance sheet totals (total assets, total debt) to compute three-year leverage trend: 10-K FY2026 balance sheet only shows FY2026 and FY2025.
• Organic Beer net sales growth excluding pricing/mix: MD&A provides shipment volume and pricing impact but not a clean organic net sales figure for Beer.
• Comparable (non-GAAP) operating income/EPS trends: MD&A references "comparable adjustments" but does not provide a full comparable EPS or operating income time series for all three years.
• Fiscal 2027 outlook quantification: MD&A provides qualitative expectations (e.g., "shipment volume to generally align with depletion volume," "depletion volume to outpace shipment volume") but no numerical guidance for revenue, EPS, or cash flow.